Circio Holding ASA

Circio Holding ASA

Description

biotechnology company developing novel circular RNA and immunotherapy medicines

Circio Holding ASA

Address

Vollsveien 19, NO-1366 Lysaker
Lysaker, Norway

Contact

contact@circio.com

Description

biotechnology company developing novel circular RNA and immunotherapy medicines

Matchmaking

Connect with Circio Holding ASA

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

Circio Holding ASA last news

13/06/2024

Circio Holding ASA - Bridge financing requested from Atlas

Oslo, 13 June 2024: Reference is made to the stock exchange announcement by Circio Holding ASA (OSE:CRNA) ("CIRCIO" or the "Company") on 29 May 2024 regarding the terms and key information of the planned rights issue to raise gross proceeds of up to NOK 52 million (the "Rights Issue"), including the commitment by Atlas Special Opportunities, LLC ("Atlas") to provide the Company with financing until completion of the Rights Issue by subscribing for bonds with a nominal value of NOK 4 million (the "Bridge Financing"). The Company has by a notice of exercise under the investment agreement

06/06/2024

Circio Holding ASA: Registration of share capital increase following conversions of convertible bonds and change of the ratio of subscription rights in the Rights Issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 6 June 2024: Reference is made to the stock exchange announcement by Circio Holding ASA (OSE:CRNA) ("CIRCIO" or the "Company") on 30 May and 3 June 2024, regarding the requested conversions of convertible bonds by Atlas Special

29/05/2024

Circio Holding ASA - Terms of the rights issue and related transactions

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 29 May 2024: Reference is made to the stock exchange announcement made by Circio Holding ASA (the "Company") on 17  April 2024, regarding the Company's intention to carry out a rights issue (the "Rights Issue"). The board of